Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Psoriasis × abrocitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 2 Psoriasis 1 Plaque, Amyloid 1 Dermatitis, Atopic 1

Interventions

tofacitinib 7 Etanercept 4 deucravacitinib 2 Methotrexate 2 Adalimumab 2 sotrastaurin 1 sodium luminolate 1 secukinumab 1 ixekizumab 1 calcipotriene 1 baricitinib 1 apremilast 1 abrocitinib 1 Anti-Infective Agents, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02201524 2016-10-05

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Pfizer

Phase 2 Terminated

59 enrolled 18 charts

Lymphoma, Follicular, Psoriasis, Plaque, Amyloid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡